Chimerix (CMRX) PT Lowered to $10 at Cowen on Tembexa Sale and "More Challenging Than Expected" Path to Approval
Tweet Send to a Friend
Cowen analyst Joseph Thome lowered the price target on Chimerix (NASDAQ: CMRX) to $10.00 (from $18.00) while maintaining a Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
